Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients

Transplant Proc. 1998 Nov;30(7):3575. doi: 10.1016/s0041-1345(98)01141-5.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antilymphocyte Serum / therapeutic use
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Graft Rejection / drug therapy
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Kidney Transplantation / immunology*
  • Living Donors
  • Muromonab-CD3 / therapeutic use
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Opportunistic Infections / epidemiology
  • Prospective Studies
  • Transplantation, Homologous

Substances

  • Adrenal Cortex Hormones
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Mycophenolic Acid